OTC Markets OTCQB - Delayed Quote USD

The Precision Peptide Company Inc. (PNGAF)

0.1921 +0.0110 (+6.07%)

As of 12:17:47 PM EST. Market Open.

The Precision Peptide Company Moves Early on New Federal Peptide Policy, Adding All Six Covered Peptides to Its Prescription Platform

TMX Newsfile 5d ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company's Needle-Free First Strategy Already in Place as HHS Draft Policy Recognizes Non-Injectable Routes for Leading Peptides

TMX Newsfile 7d ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas

TMX Newsfile 12d ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform

TMX Newsfile 13d ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line

TMX Newsfile 19d ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Begins Development of GLP3 Patch, Its Fourth Needle-Free Peptide

TMX Newsfile 21d ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing

TMX Newsfile 28d ago

BPC.CN

PNGAF
+6.07%
XU0.F
RETRANSMISSION: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch

TMX Newsfile 1mo ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch

TMX Newsfile 1mo ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Expands U.S. Wholesale Program, Opening Distribution of Its Needle-Free Range to Clinics, Med Spas, Gyms and Retailers

TMX Newsfile 1mo ago

BPC.CN

TGT

PNGAF
+6.07%
The Precision Peptide Company Becomes Strategic Sponsor of Championing Mental Health 3 Boxing Event

TMX Newsfile 1mo ago

BPC.CN

PNGAF
+6.07%
XU0.F
The Precision Peptide Company Announces Sponsorship of Boulderthon, Boulder Colorado's Marathon Weekend

TMX Newsfile 1mo ago

BPC.CN

PNGAF
+6.07%
XU0.F

U.S. markets close in 1h 18m

The Precision Peptide Company Inc. (PNGAF)

The Precision Peptide Company Moves Early on New Federal Peptide Policy, Adding All Six Covered Peptides to Its Prescription Platform

The Precision Peptide Company's Needle-Free First Strategy Already in Place as HHS Draft Policy Recognizes Non-Injectable Routes for Leading Peptides

The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas

The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform

The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line

The Precision Peptide Company Begins Development of GLP3 Patch, Its Fourth Needle-Free Peptide

The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing

RETRANSMISSION: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch

The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch

The Precision Peptide Company Expands U.S. Wholesale Program, Opening Distribution of Its Needle-Free Range to Clinics, Med Spas, Gyms and Retailers

The Precision Peptide Company Becomes Strategic Sponsor of Championing Mental Health 3 Boxing Event

The Precision Peptide Company Announces Sponsorship of Boulderthon, Boulder Colorado's Marathon Weekend